Guaifenesin 71309-0461
Product NDC
71309-0461- Manufacturer
- Safrel Pharmaceuticals, Llc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- December 18, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 1200 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
56 TABLET, EXTENDED RELEASE in 1 BOTTLE (71309-461-56)